{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:37:38Z","timestamp":1787017058451,"version":"build-2736575974"},"reference-count":38,"publisher":"BMJ","issue":"8","funder":[{"name":"Research Fund of Uppsala County Council (ALF), Sweden"},{"name":"Hungarian Kidney Foundation"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Clin Pathol"],"accepted":{"date-parts":[[2019,4,6]]},"published-print":{"date-parts":[[2019,8]]},"abstract":"<jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>In order to improve diagnostics in pleural effusions, additional value of effusion cholesterol, carcinoembryonic antigen (CEA) and syndecan-2 assays to cytology was studied.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Biomarkers were measured in effusion supernatants from 247 patients, of whom 126 had malignant pleural involvement, and their additional diagnostic efficacy to cytology was assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Syndecan-2 measurement, although gave detectable concentrations in all effusions with highest median value in mesotheliomas, was non-discriminative between different pathological conditions. CEA concentrations exceeding 5\u2009ng\/mL cut-off point indicated carcinomas, regardless of pleural involvement, which gave a sensitivity of 62% and specificity of 100% for carcinoma. Cholesterol concentration over 1.21\u2009mmol\/L cut-off value indicated neoplastic pleural involvement with 99% sensitivity and \u2018merely\u2019 69% specificity, the latter mainly due to raised levels being associated also with benign inflammatory effusions. Combined CEA and cholesterol determinations increased the sensitivity for diagnosing carcinomatosis from 70% with cytology alone to 84% and established the correct diagnosis in 16 of 31 carcinomatosis cases with inconclusive cytology. Cholesterol measurement alone, with elevated level, in combination with absence of substantial number of inflammatory cells in effusion sediment proved to be a magnificent marker for neoplastic pleural involvement with 99% efficacy, and recognised all 36 such cases with inconclusive cytology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Simultaneous measurement of CEA and cholesterol concentrations in effusion, or at least cholesterol alone, in combination with non-inflammatory fluid cytology, provides additional specific information about neoplastic pleural involvement, and can therefore be used as an adjunct to cytology, above all, in inconclusive cases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jclinpath-2018-205650","type":"journal-article","created":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T17:36:04Z","timestamp":1556300164000},"page":"529-535","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Use of cholesterol and soluble tumour markers CEA and syndecan-2 in pleural effusions in cases of inconclusive cytology"],"prefix":"10.1136","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4988-6933","authenticated-orcid":false,"given":"Miklos","family":"Gulyas","sequence":"first","affiliation":[{"name":"Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janos","family":"Fillinger","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cytology, Kor\u00e1nyi National Institute for Pulmonology, Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0913-3622","authenticated-orcid":false,"given":"Andras D","family":"Kaposi","sequence":"additional","affiliation":[{"name":"Department of Biophysics and Radiation Biology, Semmelweis University, Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miklos","family":"Molnar","sequence":"additional","affiliation":[{"name":"Institute of Pathophysiology, Semmelweis University, Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,4,26]]},"reference":[{"key":"2025092502042616000_72.8.529.1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1155\/1999\/934146","article-title":"Immunocytochemistry and DNA-image cytometry in diagnostic effusion cytology. II. Diagnostic accuracy in equivocal smears","volume":"19","author":"Motherby","year":"1999","journal-title":"Anal Cell Pathol"},{"key":"2025092502042616000_72.8.529.2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2002\/376731","article-title":"Additional techniques in serous effusions","volume":"24","author":"Hanselaar","year":"2002","journal-title":"Anal Cell Pathol"},{"key":"2025092502042616000_72.8.529.3","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3747\/co.22.2563","article-title":"Pleural fluid tumour markers in malignant pleural effusion with inconclusive cytologic results","volume":"22","author":"Antonangelo","year":"2015","journal-title":"Curr Oncol"},{"key":"2025092502042616000_72.8.529.4","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1159\/000333895","article-title":"CA-15.3 assay in effusions: comparison with carcinoembryonic antigen and CA-125 assay and cytologic diagnosis","volume":"40","author":"Pinto","year":"1996","journal-title":"Acta Cytol"},{"key":"2025092502042616000_72.8.529.5","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0339(199906)20:6<350::AID-DC5>3.0.CO;2-7"},{"issue":"Suppl 8","key":"2025092502042616000_72.8.529.6","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/cncy.22021","article-title":"Ancillary studies in pleural, pericardial, and peritoneal effusion cytology","volume":"126 Suppl 8","author":"Sundling","year":"2018","journal-title":"Cancer Cytopathol"},{"key":"2025092502042616000_72.8.529.7","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/dc.21673","article-title":"Role of DNA flow cytometry and immunocytochemical analysis in diagnosis of malignant effusions","volume":"40","author":"Kundu","year":"2012","journal-title":"Diagn Cytopathol"},{"key":"2025092502042616000_72.8.529.8","doi-asserted-by":"publisher","DOI":"10.1378\/chest.92.2.296"},{"key":"2025092502042616000_72.8.529.9","doi-asserted-by":"publisher","DOI":"10.1378\/chest.111.4.970"},{"key":"2025092502042616000_72.8.529.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0954-6111(98)90009-9"},{"key":"2025092502042616000_72.8.529.11","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1515\/CCLM.2007.285","article-title":"Differentiating transudative from exudative pleural effusion: should we measure effusion cholesterol dehydrogenase?","volume":"45","author":"Leers","year":"2007","journal-title":"Clin Chem Lab Med"},{"key":"2025092502042616000_72.8.529.12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/135036","article-title":"Pleural fluid cholesterol in differentiating exudative and transudative pleural effusion","volume":"2013","author":"Hamal","year":"2013","journal-title":"Pulm Med"},{"key":"2025092502042616000_72.8.529.13","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-5002(01)00474-3"},{"key":"2025092502042616000_72.8.529.14","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-5002(02)00534-2"},{"key":"2025092502042616000_72.8.529.15","doi-asserted-by":"publisher","DOI":"10.1378\/chest.128.4.2298"},{"key":"2025092502042616000_72.8.529.16","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1136\/jcp.54.11.831","article-title":"Value of carcinoembryonic antigen (CEA) and cholesterol assays of ascitic fluid in cases of inconclusive cytology","volume":"54","author":"Guly\u00e1s","year":"2001","journal-title":"J Clin Pathol"},{"key":"2025092502042616000_72.8.529.17","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1242\/dev.119.3.841","article-title":"Spatial and temporal changes in the expression of fibroglycan (syndecan-2) during mouse embryonic development","volume":"119","author":"David","year":"1993","journal-title":"Development"},{"key":"2025092502042616000_72.8.529.18","doi-asserted-by":"publisher","DOI":"10.1002\/path.1312"},{"key":"2025092502042616000_72.8.529.19","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0731-7085(03)00569-7","article-title":"A sandwich ELISA for the estimation of human syndecan-2 and syndecan-4 in biological samples","volume":"34","author":"Seidel","year":"2004","journal-title":"J Pharm Biomed Anal"},{"key":"2025092502042616000_72.8.529.20","doi-asserted-by":"crossref","unstructured":"Mundt F , Nilsonne G , Arslan S , et al . Hyaluronan and N-ERC\/mesothelin as key biomarkers in a specific two-step model to predict pleural malignant mesothelioma. PLoS One 2013;8. eCollection 2013.doi:10.1371\/journal.pone.0072030","DOI":"10.1371\/journal.pone.0072030"},{"key":"2025092502042616000_72.8.529.21","first-page":"89","article-title":"Expression of genes coding for proteoglycans and Wilms' tumour susceptibility gene 1 (WT1) by variously differentiated benign human mesothelial cells","volume":"65","author":"Guly\u00e1s","year":"1999","journal-title":"Differentiation"},{"key":"2025092502042616000_72.8.529.22","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.144.3.575"},{"key":"2025092502042616000_72.8.529.23","doi-asserted-by":"publisher","DOI":"10.1097\/TA.0b013e3181c4070d"},{"key":"2025092502042616000_72.8.529.24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043049","article-title":"Syndecan-2 is a novel target of insulin-like growth factor binding protein-3 and is over-expressed in fibrosis","volume":"7","author":"Ruiz","year":"2012","journal-title":"PLoS One"},{"key":"2025092502042616000_72.8.529.25","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-1386"},{"key":"2025092502042616000_72.8.529.26","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M202435200"},{"key":"2025092502042616000_72.8.529.27","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.2885"},{"key":"2025092502042616000_72.8.529.28","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1165\/rcmb.2017-0088OC","article-title":"Syndecan-2 attenuates radiation-induced pulmonary fibrosis and inhibits fibroblast activation by regulating PI3K\/Akt\/ROCK pathway via CD148","volume":"58","author":"Tsoyi","year":"2018","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2025092502042616000_72.8.529.29","doi-asserted-by":"crossref","first-page":"80","DOI":"10.5301\/jbm.5000177","article-title":"Clinical evaluation and therapeutic monitoring value of serum tumor markers in lung cancer","volume":"31","author":"Wang","year":"2016","journal-title":"Int J Biol Markers"},{"key":"2025092502042616000_72.8.529.30","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.17219\/acem\/66372","article-title":"Usefulness of carcinoembryonic antigen in the diagnosis of small cell lung cancer combined with adenocarcinoma","volume":"26","author":"Lei","year":"2017","journal-title":"Adv Clin Exp Med"},{"key":"2025092502042616000_72.8.529.31","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19991015)86:8<1488::AID-CNCR15>3.0.CO;2-Y"},{"key":"2025092502042616000_72.8.529.32","first-page":"2947","article-title":"Clinical utility of a combination of tumour markers in the diagnosis of malignant pleural effusions","volume":"28","author":"Gaspar","year":"2008","journal-title":"Anticancer Res"},{"key":"2025092502042616000_72.8.529.33","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/cncy.21283","article-title":"Diagnostic value of tumor markers in lung adenocarcinoma-associated cytologically negative pleural effusions","volume":"121","author":"Hsieh","year":"2013","journal-title":"Cancer Cytopathol"},{"key":"2025092502042616000_72.8.529.34","doi-asserted-by":"crossref","first-page":"E340","DOI":"10.21037\/jtd.2018.04.111","article-title":"Carcinoembryonic antigen-positive pleural effusion in early stage non-small cell lung cancer without pleural infiltration","volume":"10","author":"Enz","year":"2018","journal-title":"J Thorac Dis"},{"key":"2025092502042616000_72.8.529.35","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/BF00180056","article-title":"Tumor-associated antigens in effusions of malignant and benign origin","volume":"71","author":"Ammon","year":"1993","journal-title":"Clin Investig"},{"key":"2025092502042616000_72.8.529.36","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0022-2275(20)37999-2","article-title":"Sterol synthesis in vivo in 18 tissues of the squirrel monkey, guinea pig, rabbit, hamster, and rat","volume":"24","author":"Spady","year":"1983","journal-title":"J Lipid Res"},{"key":"2025092502042616000_72.8.529.37","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.trsl.2009.12.001","article-title":"Cholesterol in pleural exudates depends mainly on increased capillary permeability","volume":"155","author":"Vald\u00e9s","year":"2010","journal-title":"Transl Res"},{"key":"2025092502042616000_72.8.529.38","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0022-2275(20)40020-3","article-title":"Cholesterol, phospholipids, and fatty acids of normal immature neutrophils: comparison with acute myeloblastic leukemia cells and normal neutrophils","volume":"20","author":"Klock","year":"1979","journal-title":"J Lipid Res"}],"container-title":["Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jclinpath-2018-205650","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:06:21Z","timestamp":1758791181000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcp.bmj.com\/lookup\/doi\/10.1136\/jclinpath-2018-205650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,26]]},"references-count":38,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,7,18]]},"published-print":{"date-parts":[[2019,8]]}},"alternative-id":["10.1136\/jclinpath-2018-205650"],"URL":"https:\/\/doi.org\/10.1136\/jclinpath-2018-205650","relation":{},"ISSN":["0021-9746","1472-4146"],"issn-type":[{"value":"0021-9746","type":"print"},{"value":"1472-4146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,26]]}}}